TEI 2306
Alternative Names: Gamma-GCE; Gamma-glutamylcysteine ethyl; γ-GCE; γ-Glutamylcysteine ethylLatest Information Update: 17 Mar 2008
At a glance
- Originator Teijin Pharma
- Class Anti-ischaemics; Ischaemic heart disorder therapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections; Myocardial ischaemia